18% of GDP, worst outcomes in the OECD
The US spends 17.6–18.0% of GDP on healthcare — $1 trillion/year more than any peer nation — and gets the worst outcomes in the OECD on life expectancy, infant mortality, maternal mortality, and chronic disease burden. 28M uninsured. 45M underinsured. Family premiums average $23,968/yr. Workers earning $60K spend 20%+ of income on healthcare once cost-sharing and denials are counted. Hospital consolidation has eliminated competition in 75% of metropolitan markets. Defensive medicine — tests ordered primarily to avoid malpractice liability — costs $200–300B/yr.
The incentive structure is wrong at every level: fee-for-service rewards volume, not outcomes. CMS projects 20.3% of GDP by 2033 under the status quo. Every other developed nation achieves better outcomes at 9–12% of GDP.
Four orthogonal axes
The architecture has four distinct concerns that operate independently. Who delivers care is separable from who pays for it; who pays is separable from who sets prices; none of those are the same as what amenities are available above the universal floor.
Single federal payer paying three delivery lanes inside the floor: (1) fee-for-service (Medicare-for-all model — independent hospitals / clinics / FQHCs / physician practices on AHQB schedules), (2) integrated managed care (Kaiser model — capitated, with service-area enrollment obligation), and (3) public delivery (Veterans Health Administration expanded to non-veterans). Optional private insurance sits outside the single payer for elective / cosmetic / premium / tail-risk care.
Medicare-style payment infrastructure extended to every American via FedCard. Three payment modalities operate alongside each other: capacity-based payment for rural and low-volume facilities (makes rural trauma viable); per-person budgets (capitation) for integrated providers; fee-for-service where volume sustains it.
AHQB sets reference prices benchmarked to VHA internal pricing + peer-country basket (DE/CA/AU/FR/JP/UK/Nordics). 120% of reference is the reimbursement cap. Coverage and cost-sharing decisions are AHQB's call. The Healthcare Cost Brake fires at the 16.8% GDP threshold.
Voluntary supplemental coverage on community-rated guaranteed-issue terms — single rooms, concierge access, faster elective scheduling, premium prosthetics, interventions AHQB has excluded as insufficient-evidence. Not bundled with the payroll tax; purchased separately.
One single payer · three delivery lanes inside · optional private outside
The single federal payer pays three delivery lanes for the essential floor: private fee-for-service providers (Medicare-for-all), integrated managed care (Kaiser model), and public delivery (VHA expanded). All three run on AHQB-set rates and are held to AHQB standards; the mix in any region depends on local capacity, geography, and population. Outside the single payer, an optional private market covers elective / cosmetic / premium / tail-risk care for those who want it — never required, never bundled with the payroll tax.
Public, salaried, integrated. Existing Veterans Health Administration infrastructure scales nationally to all Americans. Government-operated facilities and government-employed clinicians, paid by the single payer.
Multi-specialty integrated systems — public, non-profit, or private — contracted at Distributed Healthcare capitated rates with a service-area enrollment obligation: the contractor must serve the full population in its geographic catchment, not the healthier subset. Capitated payment aligns incentives toward population health.
Independent hospitals, clinics, FQHCs, and physician practices delivering care under AHQB fee schedules. The Medicare-style payment infrastructure is the rail; community organizations across public, non-profit, and private status all participate on equal AHQB-set terms, billed to the single payer.
Voluntary above-floor coverage purchased privately, on community-rated guaranteed-issue terms. Single-room stays, concierge access, faster elective scheduling, premium prosthetics, AHQB-excluded interventions. NOT bundled with the payroll tax, NOT paid by the single payer. Analogous to Medigap above Medicare.
How care reaches Americans — across all provider types
Each delivery mechanism below is offered across all the provider types above. Telehealth from a VHA clinic, a Kaiser-style integrated system, a non-profit community clinic, or a contracted private provider all run on the same AHQB rates and standards. The architecture's strength is that mechanisms are not single-source — pandemic surge, mobile health, and forensic chemistry are distributed so no one category is a single point of failure.
Routine primary care, specialty visits, hospital admissions, ED. The baseline of medical delivery; every organization type carries this.
Video, asynchronous-message, and phone consultation. Anchored physically at every Post Office 2.0 telehealth booth. Sourced from any of the four organization types.
Mobile clinic units staged from Post Office 2.0 sites; deployed to rural catchments, COMPASS-identified deserts, disaster response. Public, non-profit, and private providers all qualify.
High-complexity referral care: transplants, advanced oncology, rare-disease, complex pediatric surgery. Volume-concentrated for clinical competence. CoE designation can be public, non-profit, or private — the criterion is outcomes against AHQB evidence thresholds.
Surge capability — staff, beds, supply chain, lab capacity — funded as standing capacity rather than per-procedure. Distributed across organization types so a single category isn't a single point of failure.
Every overdose case sampled at point of medical contact contributes to a national chemical-signature database tracing synthesis routes back to manufacturers and distributors. Each overdose response becomes intelligence against the supply network.
American Healthcare Quality Board — the Fed-style expert board for medicine
The American Healthcare Quality Board (AHQB) is structured like the Federal Reserve — independent, Senate-confirmed with staggered terms, insulated from political direction. It holds three distinct authorities:
The American Healthcare Quality Board publishes evidence-based clinical guidelines with mandatory literature review and public comment. Providers who follow and document American Healthcare Quality Board guidelines have a complete statutory defense against malpractice liability. Defensive medicine costs $200–300B/yr today — the incentive to order unnecessary scans ‘to cover yourself’ disappears when documented protocol compliance is the legal shield.
No procedure, device, or drug is reimbursed above 120% of a benchmark drawn annually from high-credibility allied nations (Germany, Canada, Australia, France, Japan, UK, Nordics). The VA has run this for pharmaceuticals since the 1990s at 40–70% below commercial prices. Extended to all covered services. Where a pharma company refuses to offer a drug at the reference price, the American Healthcare Quality Board can authorize compulsory licensing for any drug whose patent received US taxpayer R&D funding — which is most of them.
When Distributed Healthcare costs approach the 16.8% GDP brake, the Healthcare Cost Brake fires and American Healthcare Quality Board — not Congress, not the White House — decides where reductions fall. Coverage decisions are circumstance-specific, not categorical: interventions with strong comparative-effectiveness evidence are protected; interventions with minimal measurable benefit in specific clinical contexts (e.g., high-intensity ICU care in confirmed terminal circumstances) may be excluded from Distributed Healthcare reimbursement. Full written rationale, comment periods, and formal appeal rights are published for every limitation. Private supplemental coverage remains available for anyone who wants coverage beyond what the evidence supports.
Healthcare Cost Brake — the 16.8% GDP ceiling
The Healthcare Cost Brake is one of the six macrogovernors: when Distributed Healthcare costs exceed 16.8% of GDP, an American Healthcare Quality Board fee clawback (0–2%) activates automatically. This is a cost-side action only — no tax adjustment is made. The fiscal trajectory is protected by the Debt Sunset Governor separately; if healthcare containment succeeds inside the domain, no tax response is required.
Layered response: the Healthcare Cost Brake contains a cost problem within the healthcare system. Only if that containment fails — and the fiscal trajectory drifts below projection — does the Debt Sunset Governor fire, raising payroll tax and the top income tax rate in coupled 0.25pp steps.